Why RoslinCT

Your Trusted Partner of Choice

High-end, innovative and tailored cell therapy CDMO solutions

Deep Scientific Expertise and Diversity of Cell Platform Experience

Support autologous and allogeneic products across a variety of cell types / platforms including but not limited to iPSC, CAR-T, NK, TCR, Treg, TIL, MSC

Generation and cGMP banking of iPSC lines

Pioneers in stem cell-based services and as one of the first in the world to produce clinical-grade human pluripotent cells, extensive experience with a range of reprogramming technologies, gene editing, expansion strategies, and all aspects of quality control testing

RoslinCT is manufacturing world’s-first CRISPR-based therapy

RoslinCT developed, from early process development through commercialization, the First CRISPR-based therapy, exa-cel for the treatment of sickle cell disease and beta-thalassemia.

Process and Analytical Development Laboratory

11 Process Development and Analytical laboratories totaling >10,000 square feet designed for customer collaborations and leveraging innovative platforms to optimize manufacturing and analytical approaches

Clinical and Commercial Manufacturing Capacity

22 transatlantic purpose-built cGMP processing suites capable of meeting both US and EU regulatory requirements for clinical and commercial manufacturing

Integration of Best-in-Class Cell Therapy Software Solutions

Integrated software solutions enable electronic batch records supporting real-time monitoring, testing and release of products, as well as management of inbound and outbound logistics

Extensive Training

Specialized training programs to develop and maintain a highly skilled workforce, ensuring our staff remains at the forefront of technology and innovation in the field of cell therapy development, manufacturing and analytics

Adaptive Approach to Partner Relationships

Flexible, customized and differentiated solutions for technology transfer and cGMP manufacturing that meet our partner’s unique requirements

Partner with us

RoslinCT is a premier provider of development and manufacturing services

All Cell Types. Allogeneic. Autologous.

Discover Our Key Capabilities


Cell Type Expertise  Key Processing Capabilities  Key Analytical Capabilities 
  • T cells (CD4+/CD8+, naïve/memory, effector, regulatory)
  • Hematopoietic stem cells
  • Mesenchymal stromal cells
  • Monocytes/Macrophages
  • Human Pluripotent Stem Cells (iPSCs, hESCs)
  • Differentiated iPSCs (NK, islet, cardiac, neuronal)
  • Tissue isolates (fibroblasts, epithelial cells, etc.)
  • Endothelial cells
  • Red blood cells
  • Magnetic bead-based cell selection
  • Genetic modification (lentivirus, nanoparticles, CRISPR-Cas)
  • Cell expansion
  • Multi-layer flasks/factories
  • Closed static bags
  • Perfusion wave/rocker
  • G-Rex
  • Stirred tank bioreactor
  • Closed-cell washing and concentration
  • Fill finish & cryopreservation
  • Vial fill
  • Bag fill
  • LN2 and LN2-free controlled rate freezers
  • Cell count & viability
  • Multi-color flow cytometry
  • qPCR
  • dPCR
  • Potency/cytotoxicity
  • Rapid safety testing (sterility, endotoxin)
  • Mycoplasma
  • Sterility
  • Endotoxin
  • Adventitious agent testing
  • Pluripotent cell characterization panels
  • Genomic analysis
  • and more


End-to-End Solutions

From Development to Commercialization

RoslinCT scientist smiling

Interested in Cell Therapy CDMO Services?

RoslinCT is a premier provider of development and manufacturing service